OPHTHALMOLOGY

Aflibercept With Versus Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: Optical Coherence Tomography Angiographic Changes From a Randomized Clinical Trial

Sep 19, 2026 by in OPHTHALMOLOGY Comments Off on Aflibercept With Versus Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: Optical Coherence Tomography Angiographic Changes From a Randomized Clinical Trial
HIGHLIGHTS • OCTA revealed vascular remodeling of the BNN during PCV treatment. • Combination therapy reduced BNN vessel density more than monotherapy. • Early BNN vessel density reduction predicted polyp…
read more

Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI

Sep 19, 2026 by in OPHTHALMOLOGY Comments Off on Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI
HIGHLIGHTS • UWF-OCT achieved complete measurement of tumor thickness and LBD in 100% of small and medium choroidal tumors (31/31) in a single noncontact acquisition. • SD-OCT achieved complete measurement…
read more

Second-Generation ELZA-sub400 Protocol: Individualized High-Fluence Cross-Linking for Ultra-Thin Keratoconus Corneas

Sep 19, 2026 by in OPHTHALMOLOGY Comments Off on Second-Generation ELZA-sub400 Protocol: Individualized High-Fluence Cross-Linking for Ultra-Thin Keratoconus Corneas
HIGHLIGHTS • Standard CXL protocols exclude corneas with stromal thickness below 400 µm. • Second-generation ELZA-sub400 individualizes UV fluence up to 10 J/cm². • Ectasia progression halted in 76% of…
read more

Current Concepts in Corneal Neurotization

Sep 19, 2026 by in OPHTHALMOLOGY Comments Off on Current Concepts in Corneal Neurotization
Highlights • Corneal neurotization restores sensation and improves visual acuity. • Indirect yields longer-term sensory recovery; direct offers faster sensory recovery. • Younger age and congenital etiology predict greater sensation…
read more

Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection Versus Laser

Sep 19, 2026 by in OPHTHALMOLOGY Comments Off on Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection Versus Laser
OBJECTIVE To characterize rates, timing, and predictors of retinopathy of prematurity (ROP) retreatment among infants treated with primary laser or intravitreal bevacizumab injection. DESIGN Retrospective consecutive, comparative clinical study. PARTICIPANTS…
read more
Get Clinical Tree app for offline access